{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:22:32Z","timestamp":1749417752409},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T00:00:00Z","timestamp":1178668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2007,6,20]]},"DOI":"10.1007\/s00428-007-0420-9","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T12:50:53Z","timestamp":1178628653000},"page":"619-626","source":"Crossref","is-referenced-by-count":13,"title":["A subset of colorectal carcinomas express c-KIT protein independently of BRAF and\/or KRAS activation"],"prefix":"10.1007","volume":"450","author":[{"given":"Ana","family":"Preto","sequence":"first","affiliation":[]},{"given":"C\u00e1tia","family":"Moutinho","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgia","family":"Velho","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Rebocho","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,9]]},"reference":[{"key":"420_CR1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1357-2725(99)00076-X","volume":"31","author":"LK Ashman","year":"1999","unstructured":"Ashman LK (1999) The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 31:1037\u20131051","journal-title":"Int J Biochem Cell Biol"},{"key":"420_CR2","first-page":"4879","volume":"62","author":"S Attoub","year":"2002","unstructured":"Attoub S, Rivat C, Rodrigues S, Van Bocxlaer S, Bedin M, Bruyneel E, Louvet C, Kornprobst M, Andre T, Mareel M, Mester J, Gespach C (2002) The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res 62:4879\u20134883","journal-title":"Cancer Res"},{"key":"420_CR3","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1158\/0008-5472.CAN-04-3991","volume":"65","author":"J Baranowska-Kortylewicz","year":"2005","unstructured":"Baranowska-Kortylewicz J, Abe M, Pietras K, Kortylewicz ZP, Kurizaki T, Nearman J, Paulsson J, Mosley RL, Enke CA, Ostman A (2005) Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy. Cancer Res 65:7824\u20137831","journal-title":"Cancer Res"},{"key":"420_CR4","first-page":"2200","volume":"61","author":"G Bellone","year":"2001","unstructured":"Bellone G, Carbone A, Sibona N, Bosco O, Tibaudi D, Smirne C, Martone T, Gramigni C, Camandona M, Emanuelli G, Rodeck U (2001) Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res 61:2200\u20132206","journal-title":"Cancer Res"},{"key":"420_CR5","first-page":"385","volume":"3","author":"G Bellone","year":"2004","unstructured":"Bellone G, Ferrero D, Carbone A, De Quadros MR, Gramigni C, Prati A, Davidson W, Mioli P, Dughera L, Emanuelli G, Rodeck U (2004) Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571. Cancer Biother 3:385\u2013392","journal-title":"Cancer Biother"},{"key":"420_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199707)172:1<1::AID-JCP1>3.0.CO;2-S","volume":"172","author":"G Bellone","year":"1997","unstructured":"Bellone G, Silvestri S, Artusio E, Tibaudi D, Turletti A, Geuna M, Giachino C, Valente G, Emanuelli G, Rodeck U (1997) Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol 172:1\u201311","journal-title":"J Cell Physiol"},{"key":"420_CR7","first-page":"851","volume":"29","author":"G Bellone","year":"2006","unstructured":"Bellone G, Smirne C, Carbone A, Buffolino A, Scirelli T, Prati A, Solerio D, Pirisi M, Valente G, Nano M, Emanuelli G (2006) KIT\/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. Int J Oncol 29:851\u2013859","journal-title":"Int J Oncol"},{"key":"420_CR8","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340\u20134346","journal-title":"J Clin Oncol"},{"key":"420_CR9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"420_CR10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/gcc.10310","volume":"39","author":"E Domingo","year":"2004","unstructured":"Domingo E, Espin E, Armengol M, Oliveira C, Pinto M, Duval A, Brennetot C, Seruca R, Hamelin R, Yamamoto H, Schwartz S Jr (2004) Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 39:138\u2013142","journal-title":"Genes Chromosomes Cancer"},{"key":"420_CR11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)64229-0","volume":"161","author":"JA Fletcher","year":"2002","unstructured":"Fletcher JA, Fletcher CD, Rubin BP, Ashman LK, Corless CL, Heinrich MC (2002) KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized? Am J Pathol 161:737\u2013738; author reply 738\u2013739","journal-title":"Am J Pathol"},{"key":"420_CR12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","volume":"92","author":"T Furitsu","year":"1993","unstructured":"Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y et al (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736\u20131744","journal-title":"J Clin Invest"},{"key":"420_CR13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10350-006-0503-8","volume":"49","author":"I Hassan","year":"2006","unstructured":"Hassan I, You YN, Dozois EJ, Shayyan R, Smyrk TC, Okuno SH, Donohue JH (2006) Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum 49:609\u2013615","journal-title":"Dis Colon Rectum"},{"key":"420_CR14","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2002.20.6.1692","volume":"20","author":"MC Heinrich","year":"2002","unstructured":"Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692\u20131703","journal-title":"J Clin Oncol"},{"key":"420_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577\u2013580","journal-title":"Science"},{"key":"420_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E","volume":"193","author":"S Hirota","year":"2001","unstructured":"Hirota S, Nishida T, Isozaki K, Taniguchi M, Nakamura J, Okazaki T, Kitamura Y (2001) Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol 193:505\u2013510","journal-title":"J Pathol"},{"key":"420_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bcmd.2004.11.006","volume":"34","author":"M Holdhoff","year":"2005","unstructured":"Holdhoff M, Kreuzer KA, Appelt C, Scholz R, Na IK, Hildebrandt B, Riess H, Jordan A, Schmidt CA, Van Etten RA, Dorken B, le Coutre P (2005) Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Blood Cells Mol Diseases 34:181\u2013185","journal-title":"Blood Cells Mol Diseases"},{"key":"420_CR18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.onc.1208358","volume":"24","author":"HJ Kang","year":"2005","unstructured":"Kang HJ, Nam SW, Kim H, Rhee H, Kim NG, Hyung WJ, Noh SH, Kim JH, Yun CO, Liu ET (2005) Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene 24:1066\u20131074","journal-title":"Oncogene"},{"key":"420_CR19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley Jr","year":"1999","unstructured":"Longley BJ Jr, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, Heitjan D, Ma Y (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 96:1609\u20131614","journal-title":"Proc Natl Acad Sci USA"},{"key":"420_CR20","first-page":"339","volume":"142","author":"R Matsuda","year":"1993","unstructured":"Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y et al (1993) Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 142:339\u2013346","journal-title":"Am J Pathol"},{"key":"420_CR21","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00000478-200010000-00003","volume":"24","author":"M Miettinen","year":"2000","unstructured":"Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J (2000) Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 24:1339\u20131352","journal-title":"Am J Surg Pathol"},{"key":"420_CR22","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1038\/sj.onc.1207061","volume":"22","author":"C Oliveira","year":"2003","unstructured":"Oliveira C, Pinto M, Duval A, Brennetot C, Domingo E, Espin E, Armengol M, Yamamoto H, Hamelin R, Seruca R, Schwartz S Jr (2003) BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22:9192\u20139196","journal-title":"Oncogene"},{"key":"420_CR23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.onc.1209758","volume":"26","author":"C Oliveira","year":"2007","unstructured":"Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A, Domingo E, Capelinha AF, Duval A, Hamelin R, Machado JC, Schwartz S Jr, Carneiro F, Seruca R (2007) KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26:158\u2013163","journal-title":"Oncogene"},{"key":"420_CR24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/1541-7786.MCR-06-0085","volume":"4","author":"M Puputti","year":"2006","unstructured":"Puputti M, Tynninen O, Sihto H, Blom T, Maenpaa H, Isola J, Paetau A, Joensuu H, Nupponen NN (2006) Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res 4:927\u2013934","journal-title":"Mol Cancer Res"},{"key":"420_CR25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/418934a","volume":"418","author":"H Rajagopalan","year":"2002","unstructured":"Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2002) Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status. Nature 418:934","journal-title":"Nature"},{"key":"420_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3816\/CCC.2002.n.018","volume":"2","author":"J Reed","year":"2002","unstructured":"Reed J, Ouban A, Schickor FK, Muraca P, Yeatman T, Coppola D (2002) Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. Clin Colorectal Cancer 2:119\u2013122","journal-title":"Clin Colorectal Cancer"},{"key":"420_CR27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1349-7006.2004.tb03251.x","volume":"95","author":"Y Sakuma","year":"2004","unstructured":"Sakuma Y, Sakurai S, Oguni S, Satoh M, Hironaka M, Saito K (2004) c-kit gene mutations in intracranial germinomas. Cancer Sci 95:716\u2013720","journal-title":"Cancer Sci"},{"key":"420_CR28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00384-004-0601-9","volume":"19","author":"I Sammarco","year":"2004","unstructured":"Sammarco I, Capurso G, Coppola L, Bonifazi AP, Cassetta S, Delle Fave G, Carrara A, Grassi GB, Rossi P, Sette C, Geremia R (2004) Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis 19:545\u2013553","journal-title":"Int J Colorectal Dis"},{"key":"420_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7007-2-7","volume":"2","author":"EK Schmidt","year":"2004","unstructured":"Schmidt EK, Fichelson S, Feller SM (2004) PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biol 2:7","journal-title":"BMC Biol"},{"key":"420_CR30","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.2741\/1441","volume":"9","author":"A Shafik","year":"2004","unstructured":"Shafik A, El-Sibai O, Ahmed I, Shafik AA (2004) Identification of interstitial cells of Cajal in the human rectum. Front Biosci 9:2848\u20132851","journal-title":"Front Biosci"},{"key":"420_CR31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/clinchem\/47.7.1325","volume":"47","author":"ZM Sheng","year":"2001","unstructured":"Sheng ZM, Przygodzki RM, O\u2019Leary TJ (2001) Rapid screening for KIT mutations by capillary electrophoresis. Clin Chem 47:1325\u20131326","journal-title":"Clin Chem"},{"key":"420_CR32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","volume":"154","author":"Q Tian","year":"1999","unstructured":"Tian Q, Frierson HF Jr, Krystal GW, Moskaluk CA (1999) Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154:1643\u20131647","journal-title":"Am J Pathol"},{"key":"420_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2003-07-2554","volume":"104","author":"E Wandzioch","year":"2004","unstructured":"Wandzioch E, Edling CE, Palmer RH, Carlsson L, Hallberg B (2004) Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor\/stem cell lines. Blood 104:51\u201357","journal-title":"Blood"},{"key":"420_CR34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568009053765771","volume":"5","author":"MW Wiedmann","year":"2005","unstructured":"Wiedmann MW, Caca K (2005) Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets 5:171\u2013193","journal-title":"Curr Cancer Drug Targets"},{"key":"420_CR35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.humpath.2004.11.009","volume":"36","author":"SP Wilczynski","year":"2005","unstructured":"Wilczynski SP, Chen YY, Chen W, Howell SB, Shively JE, Alberts DS (2005) Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. Human Pathol 36:242\u2013249","journal-title":"Human Pathol"},{"key":"420_CR36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/modpathol.3800623","volume":"19","author":"C Willmore-Payne","year":"2006","unstructured":"Willmore-Payne C, Holden JA, Chadwick BE, Layfield LJ (2006) Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis. Mod Path 19:1164\u20131169","journal-title":"Mod Path"},{"key":"420_CR37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.humpath.2006.01.003","volume":"37","author":"C Willmore-Payne","year":"2006","unstructured":"Willmore-Payne C, Holden JA, Hirschowitz S, Layfield LJ (2006) BRAF and c-kit gene copy number in mutation-positive malignant melanoma. Human Pathol 37:520\u2013527","journal-title":"Human Pathol"},{"key":"420_CR38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.humpath.2005.03.015","volume":"36","author":"C Willmore-Payne","year":"2005","unstructured":"Willmore-Payne C, Holden JA, Tripp S, Layfield LJ (2005) Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis. Human Pathol 36:486\u2013493","journal-title":"Human Pathol"},{"key":"420_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/cncr.21064","volume":"105","author":"C Willmore-Payne","year":"2005","unstructured":"Willmore-Payne C, Layfield LJ, Holden JA (2005) c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Cancer 105:165\u2013170","journal-title":"Cancer"},{"key":"420_CR40","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2003.99.213","volume":"21","author":"R Yorke","year":"2003","unstructured":"Yorke R, Chirala M, Younes M (2003) c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma. J Clin Oncol 21:3885\u20133886; discussion 3886\u20133887","journal-title":"J Clin Oncol"},{"key":"420_CR41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3835(03)00013-2","volume":"193","author":"L Zhou","year":"2003","unstructured":"Zhou L, An N, Haydon RC, Zhou Q, Cheng H, Peng Y, Jiang W, Luu HH, Vanichakarn P, Szatkowski JP, Park JY, Breyer B, He TC (2003) Tyrosine kinase inhibitor STI-571\/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett 193:161\u2013170","journal-title":"Cancer Lett"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-007-0420-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-007-0420-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-007-0420-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T20:03:03Z","timestamp":1587499383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-007-0420-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,9]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6,20]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s00428-007-0420-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,9]]}}}